Science Talk: Einstein Receives High-Risk/High-Reward Cancer Research Funding
Science Talk
English - December 07, 2009 05:00 - 3 minutes - 17.4 MB Video - ★★★★ - 8 ratingsCourses Education Science yeshiva university medical school Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Science Talk: Longevity Tied to Genes That Preserve Tips of Chromosomes
December 7, 2009 — Matthew Levy, Ph.D., assistant professor of biochemistry at Albert Einstein College of Medicine of Yeshiva University, has been awarded more than $700,000 by Stand Up To Cancer (SU2C) for his high-risk/high-reward cancer research. Dr. Levy's work will focus on creating self-guiding drugs that target only cancer cells, thus eliminating or significantly reducing serious or unpleasant side effects of current therapies.